本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bone Biologics Corp

0.5050
-0.0326-6.06%
成交量:36.11萬
成交額:17.50萬
市值:139.18萬
市盈率:-0.31
高:0.5300
開:0.4690
低:0.4330
收:0.5376
52周最高:2.89
52周最低:0.4330
股本:275.61萬
流通股本:275.54萬
量比:0.57
換手率:13.11%
股息:- -
股息率:- -
每股收益(TTM):-1.6080
每股收益(LYR):-2.6500
淨資產收益率:-54.96%
總資產收益率:-33.46%
市淨率:0.35
市盈率(LYR):-0.19

資料載入中...

2023/05/01

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2023/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/21

重要事件披露

8-K - Current report
2022/11/21

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/25

重要事件披露

8-K - Current report
2022/10/13

重要事件披露

8-K - Current report
2022/10/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/11

重要事件披露

8-K - Current report
2022/10/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/10/04

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/04

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/04

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/23

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/24

重要事件披露

8-K - Current report
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

SEC問詢函

CORRESP [Cover] - Correspondence